Available Technologies - Technology Categories

All Categories > Medical > Disease: Infectious Diseases


 Tech ID   Title    
24098 Simple Diagnostic Kit Designed to Rapidly Detect Drug-Resistant Bacterial Pathogens Show Detail Description
24084 One-Step Screening and Diagnostic Tests for HCV Infection Show Detail Description
24055 Shrink-Induced, Self-Driven Microfluidic Devices Show Detail Description
23865 Structure And Activity Of The Antibiotic Taromycin A Show Detail Description
23831 Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Show Detail Description
23731 Automated Point-of-Care Microfluidic Immunoassay Platform Show Detail Description
23709 Potential Novel Anti-Viral Target For Chemotherapeutics Against Picornaviruses, Such As Human Rhinovirus An Entervirus 71 Show Detail Description
23648 Production of Malarial Surface Proteins in Algae for Use as Transmission Blocking Vaccine Candidates Show Detail Description
23642 Novel Nitroimidazole Antibiotics Show Detail Description
23631 Novel Small Molecule Inhibitors of Endosomal Trafficking for the Treatment of Viral and Bacterial Infection Show Detail Description
23524 An Optical Fiber-Based Hybrid SERS Platform for In Vivo Detection of Bio-Molecules Show Detail Description
23504 Laser Based Bacterial Disruption for Treatment of Infected Wounds Show Detail Description
23440 New Antibacterial Leads Show Detail Description
23410 NOVEL THERAPEUTICS FOR TREATMENT OF PERSISTENT FUNGAL BIOFILM INFECTIONS Show Detail Description
23376 Breath Analysis for the Diagnosis and Monitoring of Sepsis and Other Serious Inflammatory States Show Detail Description
23242 Live Recombinant Tuberculosis Vaccine Show Detail Description
23219 Broad Antiviral Therapy with Membrane-Modifying Small Molecules Show Detail Description
23157 NEW PATHWAY TO FIGHT BACTERIAL, VIRAL, AND FUNGAL INFECTIONS Show Detail Description
23122 New Elastase Inhibitors for Combating P. aeruginosa Infections Show Detail Description
23054 A Novel Rapid and Highly Sensitive Cell Based System for the Detection and Characterization of HIV Show Detail Description
23040 New Antiviral Compounds Show Detail Description
22965 Novel Method to Detect and Monitor Infection and Inflammation in situ and in vivo Show Detail Description
22936 Novel Inactivated Virus Vaccine Against Herpesviruses Show Detail Description
22935 Pre-selective Anti-HIV Vectors for Improved HIV Gene Therapy Show Detail Description
22913 Method Of Modulating T Cell Activity For Treating Cancer, Autoimmune Disease, And Chronic Viral Disease Show Detail Description
22892 Novel Viral Vaccine Design Methodology Show Detail Description
22834 Novel Therapeutic Target for HIV Show Detail Description
22629 Novel Therapy for Persistent Viral Infections Show Detail Description
22460 Polypeptide And DNA Immunization Against Coccidioides Spp. Infections Show Detail Description
22413 Collaboration Opportunity: Novel Mouse Models of Human Hepatitis B Virus Infection for Drug Discovery and Vaccine Research Show Detail Description
22407 Novel Imaging Technique Combines Optical and MR Imaging Systems To Obtain High Resolution Optical Images Show Detail Description
22396 Small molecular inhibitors of hedgehog protein signaling for treating or protecting against influenza infection Show Detail Description
22371 General Method for Identifying Antimicrobial Compounds and Determining Antibiotic Sensitivity Show Detail Description
22348 New HCV Inhibitors Show Detail Description
22312 Azuvirins: Novel Peptides with Antiviral and Antineoplastic Potential Show Detail Description
22257 Inhibition Of Hepatitis C Virus Ns5a Show Detail Description
22233 Rapid Inexpensive Fluoroimmunoassay Diagnostic Chip Fabricated from Polyolefin Coated with a Thin Film Show Detail Description
22219 Novel Group A Streptococcal Vaccine and Therapeutics Show Detail Description
22192 Biological "Cloaking" of Nanoparticles for Cancer Drug Delivery Show Detail Description
21882 Chemically Novel Beta-Lactamase Inhibitors Show Detail Description
21757 Highly Potent HIV Entry Inhibitors Show Detail Description
21741 Sequence Of Mycobacterium Tuberculosis 30 And 32 Kda Proteins Show Detail Description
21738 Molecular Cloning of Mycobacterium Tuberculosis Glutamine Synthetase (58Kd) Gene Show Detail Description
21737 Adjuvant Enhancing Immunoprotective Capacity of Extracellular Proteins Against Tuberculosis Show Detail Description
21724 Improved Immunization Strategy Using Recombinant BCG Vaccines Show Detail Description
21629 Apicoplast-Deficient, Attenuated Strains of Plasmodium for Use as Malaria Vaccines Show Detail Description
21505 Molecules In Hops For Treatment of Human Pathogenic Bacteria Show Detail Description
21464 Novel Monoclonal Antibodies Against Neospora Caninum Show Detail Description
21443 A Potent Peptide Adjuvant for Vaccines and Immunotherapies Show Detail Description
21439 FirmocidinTM, A New Small-Molecule Antibiotic to Treat MRSA, Staph, and Streptococcus Infections Show Detail Description
21436 Agent to Treat and Prevent Amebiasis Show Detail Description
21394 Real Time Adaptive External Immune System Show Detail Description
21358 Serological lipid-antibody assay for monitoring tuberculosis treatment response in children and HIV co-infected patients Show Detail Description
21279 A Method to Induce CTL Response in Immune Deficient Patients Show Detail Description
21001 Chemical Modulation of Hepatitis C Virus Mutation Rates Show Detail Description
20990 Marine Natural Products Show Detail Description
20955 Self-Adjuvanting Viral, Bacterial, Parasitic, and Tumor Vaccines Show Detail Description
20951 Technologies for the Treatment of Viral Infections, Including Hepatitis C Virus (HCV) Show Detail Description
20836 Phosphonates with Reduced Toxicity for Treatment of Viral Diseases Show Detail Description
20579 Passive and Active Immunization/Vaccine for Hepatitis C Virus Show Detail Description
20540 Retrocyclins: Antiviral Circular Minidefensins That Protect Against Human Immunodeficiency Virus And Herpes Simplex Viruses Show Detail Description
20456 Safe And Potent Vaccines Against Tularemia Show Detail Description
20429 Anti-viral T-cell Therapy from Stem Cells Show Detail Description
20332 Novel Gene Therapy For Aids Using Mutated tRNA Show Detail Description
20330 Diagnostic Test for Proliferative Senescence in Immune Cells Show Detail Description
20276 Nanoparticles With Natural Antimicrobial Properties Show Detail Description
20237 Method of Producing Novel Unmarked Recombinant Vaccine Vector for Tuberculosis Show Detail Description
20195 Compounds for Treating Microbial Infections in the Oral Cavity [for Consumer Oral Health Products] Show Detail Description
20157 Broad-spectrum Antimicrobial Peptide for the Treatment of Acne and Skin Cancer Show Detail Description
20118 Anti-Microbial Targeting for Intracellular Pathogens Show Detail Description
20019 Endogenous Small Molecule Immune Response Modulator Show Detail Description
19873 Preventing HIV Infection with Bifunctional Griffithsin Analogs Show Detail Description
19713 Lead Compounds for the Development of Antimicrobials Show Detail Description
19712 Use of MshC for Development of Tuberculosis Drugs and Vaccines Show Detail Description
19687 New Derivatives of Phosphonate Compounds with Enhanced Anti-viral Activity Show Detail Description
19684 Derivatives of Novel Nucleoside Phosphonates with Anti-viral Activity Show Detail Description
19681 Vaccination Platform for Persistent Viruses Show Detail Description
19544 Natural Products for Cancer Therapeutics Show Detail Description
19491 New Treatment for Sepsis Show Detail Description
19483 Monoclonal Antibodies Immunoreactive with Lipolysaccharide Binding Protein (LBP) and Methods of Their Use Show Detail Description
19482 Therapy for Septic Shock Show Detail Description
19475 Disease Treatments Using Multimeric TNFSF Ligands Show Detail Description
19465 Biosynthesis Of Salinosporamide A And Analogs Show Detail Description
19462 Uncovering the Genetic Basis of Phenotypic Change Show Detail Description
19453 Mitigating The Lethal Coagulopathy Of Sepsis Show Detail Description
19452 RNA ‘Friendly’ Ligands with Antiviral Activity for the Treatment of Hepatitis C Show Detail Description
19438 Improved Means to Treat Intestinal Nematode Diseases of Animals and Prevent Drug Resistance Show Detail Description
19417 Vaccines Against Acne and Acne-Associated Diseases Show Detail Description
19392 HIV Gene Therapy Treatment Show Detail Description
19299 Marine Organism Yields a Patented Family of Antitumor/Antibiotic Compounds Show Detail Description
19207 Compositions and Methods for Activating Toll-Like Receptors Show Detail Description
19132 NOVEL SMALL MOLECULES FOR THE TREATMENT OF PARASITIC DISEASES: TRICHOMONIASIS, MALARIA, CHAGAS DISEASE Show Detail Description
19107 NOVEL PRENATAL DIAGNOSTIC BIOMARKERS FOR CYTOMEGALOVIRUS INFECTION Show Detail Description
19090 STRAINS AND PLASMIDS FOR MAKING HOMOZYGOUS KNOCKOUTS IN C. ALBICANS Show Detail Description
19055 POTENT DOMINANT NEGATIVE TRANSCRIPTIONAL INHIBITORS Show Detail Description
19014 Novel Pro-Drug Technology for Targeted Delivery of Therapeutic Agents Show Detail Description
17040 Mycobacterial sulfation pathway proteins and methods of use thereof Show Detail Description

Back To Search

University of California
Innovation Alliances and Services

1111 Franklin Street, 5th Floor, Oakland, CA 94607-5200 | http://www.ucop.edu/ott/
Tel: 510.587.6000 | Fax: 510.587.6090 | UC.technologies@ucop.edu